About the Journal
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.Read More About the Journal
Samantha B. Kemp, et al.
Noted This Week
Guardant Health laid off about 7% of its staff. The decision was made, the company said, to "better support both our near- and long-term growth as well as out path to profitability. This decision puts us in an even better position to deliver on the promise we made ten years ago to transform cancer care." The company makes the Guardant360 assay and blood tests to help inform treatment decisions, monitor treatment response, and detect recurrent/residual disease.